Stay
current with links to updates regarding BDI, our manufacturing trade
partners and industry events.
|
| Hurricane Sandy - Update from BDI
Pharma |
| Important Message from BDI Pharma regarding
Hurricane Sandy |
| Columbia, SC (PRWEB) October 31, 2012 -
BDI Pharma is dedicated to continuity of service regarding the distribution of product during the current weather conditions as a result of Hurricane Sandy.
Read More. |
| |
| |
| Specialty Pharmacy Segment Growth Persists for Biopharm Manufacturers and BDI Pharma
|
| Over the past several years, the pharmaceutical industry has come to recognize the significant value that specialty pharmacies provide to patients and prescribers, alike. As a result, the pipelines of these same manufacturers are filled with products, each in various phases of study, which will be relying on this new class of trade to dispense, or administer, and monitor to ensure that the greatest efficacy can be derived from the use of their particular biopharmaceutical drugs.
|
| Columbia, SC (PRWEB) August 30, 2012
- Over the past several years, the pharmaceutical industry has come to recognize the significant value that specialty pharmacies provide to patients and prescribers, alike. With that recognition has come the realization by Big Pharma that this class of pharmacy, the fastest growing sector of healthcare provider, also affords a manufacturer with tremendous value in the critical areas of compliance and persistency – criteria that truly define whether or not a drug impacts the patient as intended, thus providing the prescriber with the outcome that was promised. Read
More |
| |
|
Industry Experience Remains Cornerstone of Success for Biotech Distributor BDI Pharma
|
| With a management team comprising over 150 years of cumulative industry tenure and knowledge, BDI Pharma continues to set the stage for growth among an otherwise challenging healthcare market.
|
| Columbia, SC (PRWEB) August 27, 2012
- In a year already defined by record sales and distribution, BDI Pharma, Inc. (BDI), the nation's fastest growing national distributor of specialty biotherapeutics, announced that the company’s forecast for calendar year Q3 exceeds that of the previous two quarters of 2012.
Read
More |
| |
| Biotech Distributor BDI Pharma Launches New Mobile Website
|
| Custom interfaces for mobile phones and tablet devices create user-friendly options for accessing resources while on the go. |
| Columbia, SC (PRWEB) July 25, 2012
- BDI Pharma, Inc. (BDI), the nation's fastest growing national distributor of specialty biotherapeutics,
launched a new mobile optimized website for smart phones and tablet
devices earlier this month. The site, http://www.bdipharma.com (also
accessible at http://www.ivig.com) is designed to offer all of the
most commonly used resources from the company, now in a
mobile-friendly format.
Read More |
| |
| |
|
Significant Growth Continues for BDI Pharma; Ongoing Developments in Biopharmaceuticals, Specifically IVIG, Confirm Optimistic Outlook for Specialty Distributor. |
| Specialty biotech distributor BDI Pharma announced that Sales Revenues through the first two fiscal quarters of 2012 represented an increase of more than thirty-five percent (35%) compared with the same time period in 2011, with both Hemophilia and IVIG sales continuing to track ahead of 2011 in both revenue and units of distribution.
|
| Columbia, SC (PRWEB) July 19, 2012
- BDI Pharma, Inc. (BDI), the nation's fastest growing national distributor of specialty biotherapeutics, announced that Sales Revenues through the first two fiscal quarters of 2012 represented an increase of more than thirty-five percent (35%) compared with the same time period in 2011.
Read More |
| |
| 2012 Proves to Be Strong Year for Anti-Hemophilic Factor Distribution, Despite Market Competition
|
| Strategic focus and robust portfolio of services continue to create record distribution trend for specialty biotech distributor BDI Pharma. |
| Columbia, SC (PRWEB) June 21, 2012 -
(BDI), the nation’s fastest growing national distributor of biotech therapies, after finishing the previous calendar year with a record level of distribution in anti-hemophilic factor (AHF), announced today that through the first five (5) months of 2012, the company’s distribution is tracking twenty-eight percent (28%) ahead of the sales volume during the same time period in calendar year 2011.
Read
More |
| |
|
2012 Proves to be Strong Year for IVIG Distribution, Despite Market Conditions
|
|
Strategic focus and enhanced partnerships create record distribution trend for specialty biotech distributor.
|
|
Columbia, SC (PRWEB) May 31, 2012 - BDI Pharma, Inc. (BDI), the nation’s fastest growing national distributor of biotech therapies, announced that the company’s distribution of intravenous immune globulin (IVIG) is tracking greater than seventy-six percent (76%) ahead of the volume distributed by BDI during the same time period in calendar year 2011.
Read More |
|
|
|
1st Quarter Sales Surpass Projections for BDI Pharma
|
|
Specialty biotech distributor announces 42% increase for FY2012 over the same period in 2011
|
|
Columbia, SC (PRWEB) April 20, 2012 - BDI Pharma, Inc. (BDI), the nation’s fastest growing national distributor of biotech therapies, announced that Sales Revenues for the first quarter of its fiscal year (calendar year 2012) represented an increase of more than forty-two percent (42%) compared with the same period during calendar year 2011.
Read More |
|
|
|
BDI Pharma Continues to Strengthen Private Practices and Clinics Across America
|
|
Specialty biopharmaceutical distributor continues to alleviate the pressures faced by smaller clinics and practices through their purchasing and rewards programs.
Read More |
|
|
|
Zensar Technologies and BDI Pharma Engage for Business Growth |
| PRINCETON, N.J., Jan. 31, 2012 (GLOBE NEWSWIRE) -- Zensar Technologies today announced the successful Go Live of the SAP ERP and CRM at BDI Pharma Inc. The project was delivered through a collaborative engagement between BDI Pharma, Inc. and Zensar Technologies, and their teams of SAP and Industry Experts.
Read More |
| |
| 2011
Brings Record Revenues for BDI Pharma |
| History of Double -Digit Annual Growth
Continues for BIopharmaceutical Distributor |
| Columbia, SC (PRWEB) January 25, 2012
- BDI Pharma, Inc. (BDI), the nation’s fastest growing national distributor of biotech therapies, announced that sales revenues for the twelve months of fiscal year 2011 represented an increase of more than twenty-nine percent (29%) compared with the same period during calendar year 2010
Read More |
| |
|
Oncology Drives Biopharm Distributor’s Q3 Growth
|
| BDI Pharma continues growth in Oncology sector and commits resources to future expansion.
|
| Columbia, SC (PRWEB) November 30, 2011 - BDI Pharma, Inc. (BDI), the the nation’s fastest growing national distributor of specialty biotherapeutics, announced that the company’s
Oncology Sales in Q3 represented a thirty-two percent (32%) increase over Q2 2011. This continued expansion resulted in overall Sales Revenues for the third fiscal quarter (Q3) of 2011 reflecting an increase of more than thirty-six percent (36%) compared with the same time
period in 2010.
Read More |
| |
| Biotech Distributor BDI Pharma’s Oncology Reward Program Continues to Pick up Momentum…and Membership
|
| Columbia, SC (PRWEB) October 31, 2011 - BDI Pharma, Inc.’s purchas
ing programs and secure, authorized supply channel provide oncology practitioners and clinics of every size with true value, quantifiable savings and genuine peace of mind.
Read More |
| |
|
Biotech Distributor BDI Pharma Achieves 100%
Seasonal Flu Vaccine Fulfillment Rate; Sets Sights on 2012-2013 Pre-Book Campaign
|
| Columbia, SC (PRWEB) September 29, 2011- National Biotech Distributor BDI Pharma successfully concludes 2011-2012 FLU season and begins pre-booking process for next year’s seasonal influenza virus vaccine.
Read More |
| |
| Specialty Pharmaceutical Distributor BDI Pharma, Inc. Supports HAE Association’s National Patient Conference
|
| Columbia, SC (PRWEB) September 26, 2011 - National Biotech Distributor BDI Pharma was recently instrumental in providing significant support for the Hereditary Angioedema Association’s (HAEA) National Patient Conference on September 16th through 18th held in Las Vegas. The company, highly skilled in the distribution of products for the treatment of HAE, has provided support to the association for the past two years.
Read More |
| |
| Partial-Year Revenues for BDI Pharma Top 300% Growth Over Entire FY2010
|
| Columbia, SC (PRWEB) August 25, 2011 - From January until August of 2011, BDI Pharma has already surpassed 2010 annual revenues within its Branded Oncology specialty pharmaceutical portfolio. The company continues to expand through the addition of sales personnel, innovative ordering programs and service offerings dedicated specifically to supporting those who care for patients suffering from cancer and other rare disease states.
Read More |
| |
| |
| BDI Pharma Q2 Revenues Rise; Sales and Distribution for 2011 Maintain Momentum
|
| Columbia, SC (PRWEB) July 18, 2011Specialty biotech distributor BDI Pharma
announced that Sales Revenues for the second fiscal quarter of 2011
represented an increase of more than twenty-three percent (23%)
compared with the same time period in 2010, with the Oncology and
Animal Health division continuing to track ahead of 2010 in both
revenue and distribution for the quarter and the year, as well.
Read More
|
|
|
Biotech Distributor Announces Success of Corporate Website as
Healthcare Resource |
| BDI Pharma's corporate website
bdipharma.com continues record of success as industry-renowned
reference tool for the healthcare market. |
| Columbia, SC
(PRWEB) May26, 2011 - BDI Pharma, Inc the nations fastest growing
distributor of biotech therapies, announced a new record number of
daily hits on the corporate web site, bdipharma.com.
Since April, the daily count has exceeded well over 31,000 hits on
multiple occasions. As for an average, the site is tracking
well over 24,000 hits on a daily basis for all of 2011 to date.
Read More |
| |
| Animal
Health Division Represents Growth of Biotech Distributor |
| Specialty biotech distributor announces
twenty-five percent (25%) monthly growth rate of animal health
division within rapidly expanding marketplace. |
| Columbia, SC - (PRWEB) May 06, 2011 - BDI Pharma, Inc., the nation’s fastest growing distributor of biotech therapies, announced continued growth in its expansion into the animal health market. 4legPharma, the Animal Health Division of BDI Pharma.
Read More |
| |
| Biotech Distributor BDIPharma, Inc. Introduces BDIAccess
|
| Columbia, SC - (PRWEB) April 22, 2011 - Biotech distributor BDI Pharma, Inc. (BDI) introduces BDIAccess, a supplemental reimbursement resource designed to assist medical providers with navigating through the complexities of reimbursement.
Read More |
| |
|
Biopharmaceutical Distributor BDI Pharma Reports Strong Q1 Revenues |
| Columbia, SC - (PRWEB) - April 15, 2011 BDI Pharma, Inc. (BDI), the nation’s fastest growing national distributor of specialty biotherapeutics, announced that Sales Revenues for the first fiscal quarter of 2011 represented an increase of more than twenty-two percent (22%) compared with the same time period in 2010.
Read
More |
| |
| |